Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.

Item
http://www.wikidata.org/entity/Q37558705
Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammationEffects of glucagon-like peptide 1 on glycemia control and its metabolic consequence after severe thermal injury--studies in an animal modelGastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.The cardiovascular effects of glucagon-like peptide-1 receptor agonists: a trial sequential analysis of randomized controlled trials.Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis.Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-AnalysisImpact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysisAn adaptive, dose-finding, seamless phase 2/3 study of a long-acting glucagon-like peptide-1 analog (dulaglutide): trial design and baseline characteristics.Defining the importance of daily glycemic control and implications for type 2 diabetes management.Progress in structure based drug design for G protein-coupled receptors.Metal-based anti-diabetic drugs: advances and challenges.Anti-obesity drugs: past, present and future.[I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation.
P2860

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.

Item
http://www.wikidata.org/entity/Q37558705
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
@en
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
@nl
type
label
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
@en
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
@nl
prefLabel
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
@en
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
@en
P2093
P2860
P304
P31
P356
10.1111/J.1742-1241.2009.02086.X
P433
P478
P50
P577
P698
P921